Table E2.
Characteristic | No. of children (%) |
---|---|
Age at study entry (mo), median (range) | 3.7 (11.7) |
Sex: male | 106 (61) |
Parental history of asthma | 36 of 173 (21) |
Prematurity | 23 of 172 (13) |
Comorbid medical disorder | 11 (6) |
History of atopic dermatitis | 30 (17) |
Siblings | 133 (76) |
Exposure to smoking during pregnancy or early childhood | 28 (16) |
Breast-feeding | 155 of 174 (89) |
Hospitalization ≥3 d | 64 (37) |
ICU stay | 12 (7) |
Systemic corticosteroid | 12 of 174 (7) |
Virus positive | 157 (90) |
RSV∗ | 111 (63) |
RV† | 19 (11) |
RV-A | 2 (1) |
RV-B | 0 (0) |
RV-C | 17 (10) |
RV-B + RV-C | 0 (0) |
RV + RSV‡ | 6 (3) |
Non-RSV/-RV | 39 (22) |
Human metanpneumovirus | 10 (6) |
Parainfluenzavirus 1 | 4 (2) |
Parainfluenzavirus 3 | 3 (2) |
Adenovirus | 1 (1) |
Coronavirus HKU1 | 1 (1) |
Coronavirus NL63 | 1 (1) |
Influenza virus A | 1 (1) |
Negative for tested viruses | 18 (10) |
ICU, Intensive care unit.
Including coinfection with viruses other than RV.
Including coinfection with viruses other than RSV.
Including coinfection with viruses other than RV or RSV.